79 related articles for article (PubMed ID: 4955784)
1. [Experiments with depot vaccines].
Henneberg G
Arzneimittelforschung; 1965 Sep; 15(9):1003-8. PubMed ID: 4955784
[No Abstract] [Full Text] [Related]
2. [The influence of the first antigenic stimulus upon further immunizability. Guinea pig experiments with poliomyelitis virus vaccines].
Sandow J
Zentralbl Bakteriol Orig; 1969; 209(3):389-406. PubMed ID: 5379832
[No Abstract] [Full Text] [Related]
3. Further investigations on the immunogenic activity of aqueous and aluminum oxide adsorbed inactivated poliovirus vaccines in Macaca mulatta.
Drescher J; Grützner L; Godglück G
Am J Epidemiol; 1967 May; 85(3):413-23. PubMed ID: 4960865
[No Abstract] [Full Text] [Related]
4. Antigenic potency of inactivated poliovirus vaccines.
Moynihan M; Petersen I
Dev Biol Stand; 1981; 47():129-33. PubMed ID: 6262143
[TBL] [Abstract][Full Text] [Related]
5. Antigen adjuvants.
White RG
Mod Trends Immunol; 1967; 2():28-52. PubMed ID: 4871640
[No Abstract] [Full Text] [Related]
6. Comparison of the effects of five adjuvants on the antibody response to influenza virus antigen in guinea pigs.
Robuccio JA; Griffith JW; Chroscinski EA; Cross PJ; Light TE; Lang CM
Lab Anim Sci; 1995 Aug; 45(4):420-6. PubMed ID: 7474883
[TBL] [Abstract][Full Text] [Related]
7. Sensitization of guinea-pigs to measles vaccines.
Aprile MA; Kadar D; Wilson S
Clin Exp Immunol; 1969 Nov; 5(5):531-9. PubMed ID: 4982816
[TBL] [Abstract][Full Text] [Related]
8. Comparisons of poliovirus antigen measurements in vitro and in small animals.
von Seefried A; Bryce E; Campbell JB; Chun JH; Laurence GD; Scollard N; Tsai KS
Dev Biol Stand; 1981; 47():91-100. PubMed ID: 6262165
[No Abstract] [Full Text] [Related]
9. Hyperpotentiation by synthetic double-stranded RNA of antibody responses to influenza virus vaccine in adjuvant 65.
Woodhour AF; Friedman A; Tytell AA; Hilleman MR
Proc Soc Exp Biol Med; 1969 Jul; 131(3):809-17. PubMed ID: 4978245
[No Abstract] [Full Text] [Related]
10. The clinical application of adjuvant 65.
Hilleman MR; Woodhour A; Friedman A; Weibel RE; Stokes J
Ann Allergy; 1972 Mar; 30(3):152-8. PubMed ID: 4622116
[No Abstract] [Full Text] [Related]
11. Lack of adjuvant effect of A1PO4 on purified influenza virus hemagglutinins in man.
Davenport FM; Hennessy AV; Askin FB
J Immunol; 1968 May; 100(5):1139-40. PubMed ID: 5648476
[No Abstract] [Full Text] [Related]
12. [Letter: "Seroconversion rate" after influenza immunization].
Günther O; Seinsche D; von Mettenheim A
Dtsch Med Wochenschr; 1974 Mar; 99(12):597. PubMed ID: 4599075
[No Abstract] [Full Text] [Related]
13. Potency test of inactivated polio vaccines in guinea pigs.
Lapinleimu K; Stenvik M
Dev Biol Stand; 1981; 47():109-12. PubMed ID: 7014296
[TBL] [Abstract][Full Text] [Related]
14. Influenza vaccine immunogenicity in 6- to 23-month-old children: are identical antigens necessary for priming?
Walter EB; Neuzil KM; Zhu Y; Fairchok MP; Gagliano ME; Monto AS; Englund JA
Pediatrics; 2006 Sep; 118(3):e570-8. PubMed ID: 16950948
[TBL] [Abstract][Full Text] [Related]
15. Influenza vaccine response following its simultaneous application with BCG 1st report.
Zykov MP; Raphaelskaya TI
Z Erkr Atmungsorgane; 1981; 156(3):203-11. PubMed ID: 7293275
[TBL] [Abstract][Full Text] [Related]
16. POLIOVIRUS VACCINES IN MINERAL OIL ADJUVANT. I. ANIMAL TOXICITY AND SEROLOGIC RESPONSE DATA.
HILLEMAN MR; HAMPIL B; SWEET BH
J Allergy; 1963; 34():413-9. PubMed ID: 14066383
[No Abstract] [Full Text] [Related]
17. Simultaneous administration of meningococcal C conjugate vaccine and diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae type b conjugate vaccine in children: a randomized double-blind study.
Halperin SA; McDonald J; Samson L; Danzig L; Santos G; Izu A; Smith B; MacDonald N
Clin Invest Med; 2002 Dec; 25(6):243-51. PubMed ID: 12516995
[TBL] [Abstract][Full Text] [Related]
18. Chitosan as an adjuvant for parenterally administered inactivated influenza vaccines.
Ghendon Y; Markushin S; Krivtsov G; Akopova I
Arch Virol; 2008; 153(5):831-7. PubMed ID: 18297235
[TBL] [Abstract][Full Text] [Related]
19. Inactivated influenza H5N1 whole-virus vaccine with aluminum adjuvant induces homologous and heterologous protective immunities against lethal challenge with highly pathogenic H5N1 avian influenza viruses in a mouse model.
Ninomiya A; Imai M; Tashiro M; Odagiri T
Vaccine; 2007 May; 25(18):3554-60. PubMed ID: 17293015
[TBL] [Abstract][Full Text] [Related]
20. Simultaneous application of influenza chemovaccine and "Vaxigrip" preparations with BCG.
Zykov MP; Subbotina TI; Rudenko LG; Kaplin NN
Acta Virol; 1983 Mar; 27(2):160-7. PubMed ID: 6135335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
